Literature DB >> 11216884

The development of a quantitative electroencephalographic scanning process for attention deficit-hyperactivity disorder: reliability and validity studies.

V J Monastra1, J F Lubar, M Linden.   

Abstract

The development of a quantitative electroencephalographic (QEEG)-based procedure for use in the assessment of attention deficit-hyperactivity disorder (ADHD) was examined through a series of studies investigating test reliability and validation issues. This process, involving a spectral analysis of the electrophysiological power output from a single, midline, central location (the vertex), was conducted in 469 participants, 6 to 20 years of age, classified as ADHD, inattentive type; ADHD, combined type; or control. The results indicated that the QEEG scanning procedure was reliable (r = .96), was consistent with the Attention Deficit Disorders Evaluation Scale (S. B. McCarney, 1995) and the Test of Variables of Attention (L. M. Greenberg, 1994; chi-square, p < .01), and differentiated participants with ADHD from a nonclinical control group (p < .001). The sensitivity of the QEEG-derived attentional index was 90%; the specificity was 94%.

Entities:  

Mesh:

Year:  2001        PMID: 11216884     DOI: 10.1037//0894-4105.15.1.136

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  40 in total

Review 1.  Stimulant prescription cautions: addressing misuse, diversion and malingering.

Authors:  David L Rabiner
Journal:  Curr Psychiatry Rep       Date:  2013-07       Impact factor: 5.285

2.  EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood.

Authors:  Madeline M Robertson; Sarah Furlong; Bradley Voytek; Thomas Donoghue; Charlotte A Boettiger; Margaret A Sheridan
Journal:  J Neurophysiol       Date:  2019-10-16       Impact factor: 2.714

Review 3.  Principles of medical care for children with attention deficit hyperactivity disorder.

Authors:  L S Chutko; R G Yur'eva; S Yu Surushkina; I S Nikishena; I S Yakovenko; T I Anisimova; K A Aitbekov
Journal:  Neurosci Behav Physiol       Date:  2010-03

4.  Effects of neurofeedback versus stimulant medication in attention-deficit/hyperactivity disorder: a randomized pilot study.

Authors:  Geir Ogrim; Knut A Hestad
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-06-29       Impact factor: 2.576

Review 5.  Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update.

Authors:  Sandra K Loo; Scott Makeig
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

6.  Classification Accuracy of Neuroimaging Biomarkers in Attention-Deficit/Hyperactivity Disorder: Effects of Sample Size and Circular Analysis.

Authors:  Alfredo A Pulini; Wesley T Kerr; Sandra K Loo; Agatha Lenartowicz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-06-27

7.  Network connectivity abnormality profile supports a categorical-dimensional hybrid model of ADHD.

Authors:  Amanda Elton; Sarael Alcauter; Wei Gao
Journal:  Hum Brain Mapp       Date:  2014-02-25       Impact factor: 5.038

Review 8.  Aberrant Modulation of Brain Oscillatory Activity and Attentional Impairment in Attention-Deficit/Hyperactivity Disorder.

Authors:  Agatha Lenartowicz; Ali Mazaheri; Ole Jensen; Sandra K Loo
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-10-06

9.  Correlation of EEG with neuropsychological status in children with epilepsy.

Authors:  David A Hsu; Katherine Rayer; Daren C Jackson; Carl E Stafstrom; Murielle Hsu; Peter A Ferrazzano; Kevin Dabbs; Gregory A Worrell; Jana E Jones; Bruce P Hermann
Journal:  Clin Neurophysiol       Date:  2015-08-20       Impact factor: 3.708

10.  Low-Resolution Electromagnetic Tomography (LORETA) of changed Brain Function Provoked by Pro-Dopamine Regulator (KB220z) in one Adult ADHD case.

Authors:  Bruce Steinberg; Kenneth Blum; Thomas McLaughlin; Joel Lubar; Marcelo Febo; Eric R Braverman; Rajendra D Badgaiyan
Journal:  Open J Clin Med Case Rep       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.